Vertex Appoints Daniel Brennan to its Board of Directors
Vertex Pharmaceuticals appointed Daniel Brennan to its Board of Directors as an independent director, expanding the board from 10 to 11 members. Brennan retired last year as EVP and CFO of Boston Scientific after more than 25 years there, bringing over 35 years of healthcare finance experience.
Key figures
- Board size after
- 11
- Board size before
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.